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Coeliac disease is associated with an increased
risk of small bowel lymphoma and
adenocarcinoma.' The earliest association
betweencoeliacdiseaseandmalignantlymphoma
was reported by Fairley and Mackie (1937).2
Histological stains enabled the identification of
T-celllymphoma,nowdesignatedasenteropathy-
associated T-cell lymphoma (EATL) as the most
commonneoplasm(96%)associatedwithcoeliac
disease in one series,3 and B-cell lymphoma
accounting for the remaining 4%. The cause for
this association remains uncertain. HLA
genotyping has indicated that lymphoma is more
common in DQA1*0501, DQB1*0201
individuals.4
Small bowel malignancy typically occurs in the
fifth to seventh decades of life. Recent studies
using population screening have provided an
estimate of prevalence of coeliac disease (in
particular, 1 in 122 in Northern Ireland 5; 5.3 in
1000 in Sweden 6and4.9 - 5.7 in 1000 in Italy 7).
The common presentations of lymphoma are an
exacerbation of their underlying disease (e.g.
diarrhoea, pain, abdominal mass, weight loss) or
a surgical complication (e.g. perforation,
obstruction). We report a case ofcoeliac disease
presenting with colonic lymphoma.
CASE REPORT A 63 year old man presented
with one-month history of nausea, vomiting,
diarrhoea and weight loss. He had a history of
heavy alcohol consumption and previous bouts
of morning diarrhoea for two years. Physical
examination was unremarkable. Full blood
picture, electrolytes and liverfunction tests were
normal; the albumin was low. Following
admission,hedevelopedintermittentpyrexiaand
persistent diarrhoea despite anti-diarrhoeal
medication.
On admission, antibodies to endomysium and
tissue transglutamase (31Eu/ml, normal: 0-25)
were positive. Endomysial antibodies were
measuredbyimmunofluorescencewithatitre 1:5
or greater taken as positive, and tissue
transglutamasewasmeasuredbyimmunosorbent
assay (ELISA). OGD was performed, and
duodenal biopsy showed partial villous atrophy.
Colonoscopy showed a large flat ulcer at the
distal transverse colon and biopsies revealed
mucosal inflammation with no evidence of
malignancy. Hewascommencedonagluten-free
diet. Ten days later, he developed two large
episodes ofbrightredbleeding perrectum which
requiredbloodtransfusion; howeverhecontinued
to bleed and 48 hours later, laparotomy was
undertaken.
At laparotomy, the ulcerated area of colon was
identified and transverse colectomy was
performed. It was also noted that a segment of
ileum was thickened. No procedure was carried
outonthe smallbowel. Histological examination
confirmed an ulcer with appearances suggestive
of malignant lymphoma. The lymphoma was
coveredbythickinflammatoryexudates;probably
explaining the initial benign colonoscopic
biopsies. Some of the cells were positive for
CD68. The majority of cells did not stain for
either B- or T-cell markers. Therefore, it was
regarded as a non-B, non -T cell lymphoma.
Due to the appearance of the small intestines at
laparotomy, a small bowel series was carried out
which was normal. Postoperatively, he became
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verydepressedandhisappetite wanedandhewas
commencedonenteralfeeding. Threeweekslater
he had a sudden deterioration and died due to
pneumonia. Autopsy failed to show any further
evidence of systemic lymphoma.
DISCUSSION
Lymphoma accounts for approximately 0.2 to
0.6% of large bowel malignancies.8 The mean
age of presentation is 55 years with a male
preponderance.9 So far, two risk factors have
been identified: inflammatory bowel disease'0
andimmunosuppression (post-kidneytransplant,
HIV, immune disorder).11 12 In coeliac disease a
lymphocytic infiltrate develops inthe gastric and
colonic mucosa;'3 to dateno association has been
described between coeliac disease and colonic
lymphoma. Immunological changes (rises in
CD3+ and CD25+ lymphocytes and pro-
inflammatorycytokines)havebeennotedinrectal
mucosaofuntreatedcoeliacpatients,afteragluten
challenge in the form of gluten enema had been
given.14
As described above, microscopic inflammation
is present in the colon of those with coeliac
disease. It is possible that such inflammation
could predispose to malignant transformation.
Asyet, thishypothesisremains untested. Colonic
adenocarcinoma has been described in patients
withcoeliacdisease.'5Inthisreport,threepatients
suffering from coeliac disease were found to
have a right sided colonic adenocarcinoma. One
patient was diagnosed with coeliac disease ten
years previously and ulcerative colitis six years
afterthat. Theremainingtwohadthediagnosisof
carcinoma and coeliac disease made within
months of each other. There is one other
documentedcaseofcolonic lymphomaincoeliac
disease.16This washistologically averydifferent
lesionfromthiscase,beingadiffusedifferentiated
T-cell lymphoma, which was treated primarily
by chemotherapy.
Thereareseveralhistopathologicalclassifications
oflymphoma due to the diverse morphology and
cellular polymorphism of the disease.
Descriptions such as malignant lymphomatous
polyposis, tumours of mucosa-associated
lymphoid tissue, tumours of 'centrocyte-like
cells', 'maltoma' and polymorphic B-cell
lymphomas have been used. Most
immunohistochemical studies ofgastrointestinal
lymphoma have reported that the majority of
tumours are of B-lineage via immunoreactivity
with one or more B-cell markers.'7 However,
some cases of high-grade lymphoma failed to
stain with anti-leukocyte common antigen. In
this case, tumour cells may stain positive for
otherantibodiesthatrecogniseleucocytecommon
related antigen. Yet, there is no specific
combination of antibodies that allows positive
identification of any of the histological
subgroups.18
Prognostic data ofprimary colorectal lymphoma
in the literature is scarce. Although histological
stage significantly correlates with survival, in
several series different pathological
classifications were used. In another series, the
presence of tumour cell MT2 immunoreactivity
appeared to be a better determinant ofprognosis
than histological grade.'7 Surgical resection is
recommendedforlocalisedcolo-rectal lymphoma
as it may provide important prognostic
information, offer a chance for cure, with or
without adjuvant therapy, and prevent surgical
complications."8 The value of chemotherapy,
either alone or as adjuvant therapy for colonic
carcinoma has notbeen prospectively evaluated.
Radiotherapy and/or chemotherapy may also be
of value for lymphoma with advanced stage and
high-grade lymphomas. 7
CONCLUSION
We have highlighted an uncommon disease
occurring in the context of coeliac disease. This
isthe firstreportofcoeliac disease in association
with solitary colonic lymphoma, although there
may be a possibility of the tumour occurring
coincidentally inapatientwithcoeliac disease. A
recent retrospective study in Northern Ireland
had demonstrated that a third of patients with
apparently spontaneous small bowel lymphomas
had unrecognised coeliac disease.'9 This case
may suggest that a similar search for coeliac
disease inpatients withcolonic lymphomamight
be appropriate.
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